CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases and other rare diseases, today announced that management will present at the following upcoming investor conferences:
- Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday, September 12, 2018 at 4:15 p.m. E.T. The fireside chat will be held at the Grand Hyatt New York in New York City.
- Janney Montgomery Scott Healthcare Conference on Tuesday, September 18, 2018 at 8:15 a.m. E.T. The fireside chat will be held at the Union League Club in New York City.
The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying DMD drug candidates. For more information, please visit: www.sarepta.com.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
Source: Sarepta Therapeutics, Inc.
Media and Investors:
Sarepta Therapeutics, Inc.
Ian Estepan, 617-274-4052 iestepan@sarepta.com
Or
W2O Group
Rachel Hutman, 301-801-5540
rhutman@w2ogroup.com